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This paper consists of a case history and an overview of the relationship, aetiology, and treatment of comorbid bipolar disorder
migraine patients. A MEDLINE literature search was used. Terms for the search were bipolar disorder bipolar depression, mania,
migraine, mood stabilizer. Bipolar disorder and migraine cooccur at a relatively high rate. Bipolar II patients seem to have a higher
risk of comorbid migraine than bipolar I patients have. The literature on the common roots of migraine and bipolar disorder,
including both genetic and neuropathological approaches, is broadly discussed. Moreover, bipolar disorder and migraine are often
combined with a variety of other aﬀective disorders, and, furthermore, behavioural factors also play a role in the origin and course
of the diseases. Approach to treatment options is also diﬃcult. Several papers point out possible remedies, for example, valproate,
topiramate, which acts on both diseases, but no ﬁrst-choice treatments have been agreed upon yet.
1.Introduction
Both bipolar disorder and migraine are not uncommon
diseases. Whereas disorders of bipolar spectrum have an oc-
currence rate between 0.4 and 1.4% depending on diﬀerent
studies [1], migraine has rates from 10 to 30% [22]. More
often than noticed, bipolar disorder occurs together with
migraine. In a study of patients suﬀering from bipolar dis-
order (both type I and II), Ortiz et al. [2] found comorbid
migraine in 24.5% of all bipolar cases and McIntyre et al.
[3] of 24.8% (versus a general population rate of 10.3%).
Contrary to that, Holland et al. [4]f o u n dam u c hl o w e rp r e -
valence of 4.7%. Nevertheless, comorbidity of both dis-
eases seems to be an underestimated problem. In short,
the main characteristics of bipolar disorder are recurrent
episodes of depressive and manic states. Migraine is a usual-
ly unilateral headache often combined with nausea, photo-
phobia, and others. As with bipolar disorder, migraine is
divided into diﬀerent subtypes, such as migraine with aura
and without, or familial hemiplegic migraine among others.
2. Case History
A patient in his middle ﬁfties has been suﬀering from mood
disturbances since adolescence. The patient’s family history
hints of “nerve diseases” of his mother and of his aunt and
grandmother on the mother’s side. For several days, he
was overactive and, as his brother once told him, “mad.”
The patient, during his hyperactive phase, often tried to
convince his brother to do wayward things. After some days
of hyperactivity, the patient’s mood switched overnight to
being deeply depressed, with avolition and a gloomy mood
that lasted for many weeks. When this pattern ﬁrst appeared,
it occurred every one or two months; but, in its later appear-
ances, the switching occurred monthly or within a fortnight.
The patient never underwent therapy. At the age of 20, he
had a head injury caused by an accident with his motorcycle.
(More speciﬁc data about this event were not available.)
After that, a migraine developed, which at ﬁrst was never
severe, and occurred four times a year. These early migraines
occurred independently of his bipolar disorder. In the last
ten years, however, the migraine became extremely severe on
occasion and was linked to his bipolar disorder. The linkage
is that manic states were always followed by migraine attacks
with depressive mood. With these severe migraines, the
patient experiences withdrawal, loss of interests, sleep distur-
bances, and recurrent suicidal fantasies. In addition to these
migraines which follow after manic states, other migraines
occur independently of manic states. In these last ten years,
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a zigzag pattern in visual ﬁeld, narrowing of visual ﬁeld
(tunnel view), blurred vision, and ﬂashes. Then, speech
arrest follows and palsy develops starting with lips, face,
neck, and extremities, mostly on the right site. Anterograde
amnesia follows on such a phase which lasts some hours
in diﬀerent degrees of severity. Speech arrest is usually the
longest lasting symptom. Migraine headaches endure from
1 to 3 days. Manic states usually last a few days, depressive
ones some weeks.
In recent, MRI scan was nothing abnormal detected.
EEG in symptom-free intervals revealed an unstable alpha
rhythm but no major changes. Routine laboratory data and
parametersforthyroidgland,borreliosis,andluesshowedno
abnormalities.
In the case just described, the beginning of the bipolar
disorder, presumably of type I, precedes the onset of
migraine attacks. It is a migraine of a complicated type. In
the diﬀerential, a familial hemiplegic migraine is possible.
3. Relationship betweenMigraineand
Bipolar Disorder
The literature broadly supports comorbidity of migraine and
bipolar disorder. Datta and Kumar [5] reported on a 19-
year-old patient with hypomania as an aura of migraine.
In a review, Antonaci et al. [6] unravelled a coincidence
of migraine and aﬀective anxiety disorders and, especially,
a “trend towards an association of migraine and bipolar
disorder”(seealso[7]).Moststudiessupportthatmigraineis
associated not only with bipolar disorder but also with major
depression, panic disorder, social phobia [8, 9], drug abuse
[10], suicide, and neurological and internal diseases too, for
instance stroke or hypertension [11]. Vice versa, according
to a review of literature of McIntyre et al. [12], subjects with
other neurological diseases, such as epilepsy or multiple scle-
rosis, seem to have a higher occurrence of bipolar disorder.
Are There DiﬀerencesinPrevalenceofComorbidities? Dilsaver
et al. [13] found a higher prevalence of migraine in bipolar
patients than in those who suﬀer from major depressive
disorder. In a study by Ortiz and colleagues [2], which
distinguished bipolar I from bipolar II patients, a higher
prevalence of migraine in bipolar II subjects was apparent
and, in addition, higher rates were found for suicidal
tendencies and anxiety disorders. Patients with a major
depressive episode who had a family history of bipolar
disorder had an increased risk of suﬀering from migraine
[14]. Patients with unipolar depression and migraine have
more depressive episodes in the course of time and more
often a positive family history of migraine compared to those
without comorbid migraine [15].
Does Migraine Inﬂuence the Course of Bipolar Disorder? Ac-
cording to Brietzke et al. [16], patients with both bipolar I
and bipolar II disorder who suﬀer from comorbid migraine
had more mood episodes, especially depressive ones. Fur-
thermore, they found a higher occurrence rate of other
psychiatric and general medical comorbidities.
4. Is There a Common Aetiology of
B i po l a rD i s o r d e ra n dM i gra i n e ?
Diﬀerent gene regions are suspect as being responsible for
association of bipolar disorder with migraine, but results
in studies diﬀer. One recent study [17] found no evidence
that polymorphisms of the genes ANK3 and CACNA1C in
migraine patients were associated with an elevated risk for
bipolar disorder. Another recent study [18, 19], which inves-
tigated genomewide associations, found some gene regions
which diﬀered in bipolar patients depending on whether
they were susceptible to migraine or not. Holland and Agius
[20] saw “much overlap in neuropathological mechanisms”
in both diseases. Besides genetics, they discussed altered
expression of neurotrophic factors, cellular calcium physi-
ology, endoplasmatic reticulum function, neuronal loss and
pointed out the important question of sensitisation which is
still controversially discussed: do recurrent episodes in either
the diseases facilitate further ones?
Others bring up white matter hyperintensities for discus-
sion. Gunde et al. [21] argued that high rates of such signs,
detected in neuroimaging, play an important role both in
bipolar disorder and migraine, and a substantial proportion
of the hyperintensities would be related to the comorbidity
of both diseases.
5. Treatment Options for Comorbid
Bipolar/MigrainePatients
Although there are no evidence-based treatment suggestions
for people with bipolar disorder and comorbid migraine, it
seems reasonable that substances which act on both bipolar
disorder and migraine could be used to ward oﬀ relapse. A
problem in this approach is that the particular substances
which are the drugs of choice for prophylactic treatment
of migraine—the beta antagonists—could make depressive
symptoms worse. On the other hand, valproate, which
theoretically acts on both disorders, has only an oﬀ-label
status in migraine prophylaxis [22]. Nevertheless, several
papers see beneﬁts from valproate and other substances.
Finocchi et al. [23] suggested valproate and topiramate as a
mood stabilizer in migraine without aura and lamotrigine in
migrainewithaura.Evenamitriptylinecouldbeusedforpre-
vention of mood episodes and migraine attacks. Serotonin
reuptake inhibitors (SSRIs) and serotonin norepinephrine
reuptake inhibitors (SNRIs) are recommended in migraine
patients for comorbid depression and anxiety. Caution
should be exercised when triptans are combined with SSRIs
or SNRIs because of a possible risk of serotonin syndrome
[24].
In this vein, also neuroleptics which have already been
used broadly as mood stabilizers are worth consideration,
but, in relation to migraine, no suﬃcient studies exist [25].
Last but not least, the literature (see [26]) suggests that
behavioural and cognitive-behavioural therapies are helpful
for patients with a comorbid bipolar/migraine diagno-
sis.Case Reports in Medicine 3
6. Discussion
Migraine is an important comorbid disease in bipolar pa-
tients. It not only strengthens the cause of bipolar disorder
butalsoworsenstherecurrenceratewithregardtodepressive
episodes. Bipolar II patients have a higher susceptibility of
having comorbid migraine.
The literature survey with regard to the origins of both
diseases indicates a variety of theories and working points.
It is important to consider both the multifactor genesis of
aﬀective diseases and the inﬂuence of psychic disorders on
neurological disorders such as migraine. We do not know
yet whether bipolar disorder has causal or merely accidental
connections with migraine. Nor do we know what organic
or psychic conditions might exactly link the diseases, or why
some patients have the comorbidities and others do not.
Furthermore, many other psychic and neurological disorders
can be comorbid with bipolar disorder.
There is no proven treatment regimen for migraine with
comorbid bipolar disorder, so that pharmacological therapy
isstillamatteroftrialanderror.Nevertheless,someremedies
seem to have eﬀects on both of the diseases, but one must be
wary of purchasing the beneﬁt of a remedy in one disease by
worsening the other.
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